Answers are grounded in this paper and cite their sources.
Background: Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision is standard for locally advanced rectal cancer (LARC). While tumor regression grade is routinely reported, lymph node regression grade (LRG) is underutilized. We aimed to develop a machine learning model for preoperative LRG prediction. Methods: We retrospectively reviewed 111 LARC patients who underwent nCRT plus surgery between January 2016 and December 2020. LRGmax (grades 0–5) was assessed using Mandard criteria. Elastic Net regression with 10-fold cross-validation was used for feature selection, followed by a Softmax multinomial classifier. Patients were randomly split into training (70%) and validation (30%) sets. Performance was evaluated using AUC, accuracy, sensitivity, specificity, precision, and recall. Bootstrap resampling and decision curve analysis assessed calibration and clinical net benefit. Results: The LRGmax distribution was: grade 0 (28.8%), 1 (39.6%), 2 (12.6%), 3 (10.8%), 4 (5.4%), and 5 (2.7%). In the training set, AUC was 0.99. In the validation set, AUC was 0.86 and specificity 0.87. Calibration curves showed high consistency; DCA revealed positive net benefit. Higher LRGmax correlated with increased nodal metastasis count, lymph node ratio, and worse survival (all P < 0.001). LRGmax correlated positively with radiotherapy efficacy ( r = 0.28, P = 0.003) and negatively with 3-year survival ( r = –0.47, P < 0.001). Conclusions: The Elastic Net–Softmax model showed discriminative utility for predicting LRGmax after nCRT in LARC. Despite decreased validation metrics due to limited sample size and class imbalance, the model retained predictive value as a proof-of-concept tool. Multi-center prospective studies are warranted.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: